The emergent phenomenon of aspirin resistance: insights from genetic association studies

• Type: Article in International Scientific Journal
• Date: 2020

Authors

Ferreira, M (Author) Other; Freitas Silva, M (Author) FMUP; Assis, J (Author) Other; Pinto, R (Author) Other; José Pedro Nunes (Author) FMUP; Rui Medeiros (Author) ICBAS

Journal

Title: Pharmacogenomics

Vol. 21

Pages: 125-140

ISSN: 1462-2416

Publisher: ASHLEY PUBLICATIONS LTD

Indexing

ISI Web of Knowledge - 27 Citations

Scopus - 34 Citations

Other information

Authenticus ID: P-00R-MAD

DOI: 10.2217/pgs-2019-0133

Abstract (EN): Despite the clinical benefits of aspirin, the interindividual variation in response to this antiplatelet drug is considerable. The manifestation of aspirin resistance (AR) is frequently observed, although this complex process remains poorly understood. While AR etiology is likely to be multifactorial, genetic factors appear to be preponderant. According to several genetic association studies, both genome-wide and candidate gene studies, numerous SNPs in cyclooxygenase, thromboxane and platelet receptors-related genes have been identified as capable of negatively affecting aspirin action. Thus, it is essential to understand the clinical relevance of AR-related SNPs as potential predictive and prognostic biomarkers as they may be essential to defining the AR phenotype.

Language: English

Type (Professor's evaluation): Scientific

No. of pages: 16